These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33624624)

  • 1. [Evidence-based management of primary liver cancers: cholangiocarcinoma.].
    Alvaro D; Bragazzi MC; Venere R; Ridola L
    Recenti Prog Med; 2021 Feb; 112(2):117-123. PubMed ID: 33624624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiocarcinoma 2020: the next horizon in mechanisms and management.
    Banales JM; Marin JJG; Lamarca A; Rodrigues PM; Khan SA; Roberts LR; Cardinale V; Carpino G; Andersen JB; Braconi C; Calvisi DF; Perugorria MJ; Fabris L; Boulter L; Macias RIR; Gaudio E; Alvaro D; Gradilone SA; Strazzabosco M; Marzioni M; Coulouarn C; Fouassier L; Raggi C; Invernizzi P; Mertens JC; Moncsek A; Ilyas SI; Heimbach J; Koerkamp BG; Bruix J; Forner A; Bridgewater J; Valle JW; Gores GJ
    Nat Rev Gastroenterol Hepatol; 2020 Sep; 17(9):557-588. PubMed ID: 32606456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the biology of intrahepatic cholangiocarcinoma: molecular pathways and early detection of precursor lesions.
    Gibiino G; Fabbri C; Fagiuoli S; Ianiro G; Fornelli A; Cennamo V
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):730-741. PubMed ID: 28272710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholangiocarcinoma: new insights into disease pathogenesis and biology.
    Braconi C; Patel T
    Infect Dis Clin North Am; 2010 Dec; 24(4):871-84, vii. PubMed ID: 20937455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma.
    European Association for the Study of the Liver
    J Hepatol; 2023 Jul; 79(1):181-208. PubMed ID: 37084797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatobiliary cancers, version 2.2014.
    Benson AB; D'Angelica MI; Abrams TA; Are C; Bloomston PM; Chang DT; Clary BM; Covey AM; Ensminger WD; Iyer R; Kelley RK; Linehan D; Malafa MP; Meranze SG; Park JO; Pawlik T; Posey JA; Scaife C; Schefter T; Sigurdson ER; Tian GG; Vauthey JN; Venook AP; Yen Y; Zhu AX; Hoffmann KG; McMillian NR; Sundar H
    J Natl Compr Canc Netw; 2014 Aug; 12(8):1152-82. PubMed ID: 25099447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating Hepatobiliary Cancers: The Oncology Way.
    Galle PR
    Dig Dis; 2017; 35(4):384-386. PubMed ID: 28468016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the clinical diagnosis and therapy of cholangiocarcinoma.
    Yao D; Kunam VK; Li X
    J Int Med Res; 2014 Feb; 42(1):3-16. PubMed ID: 24366497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Insight into Cholangiocarcinoma and Recent Advances in its Treatment.
    Sahu R; Sharma P; Kumar A
    J Gastrointest Cancer; 2023 Mar; 54(1):213-226. PubMed ID: 35023010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical diagnosis and staging of cholangiocarcinoma.
    Blechacz B; Komuta M; Roskams T; Gores GJ
    Nat Rev Gastroenterol Hepatol; 2011 Aug; 8(9):512-22. PubMed ID: 21808282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Overview: liver tumors].
    Graziadei I
    Wien Med Wochenschr; 2013 Mar; 163(5-6):109-12. PubMed ID: 23361850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholangiocarcinoma.
    Khan AS; Dageforde LA
    Surg Clin North Am; 2019 Apr; 99(2):315-335. PubMed ID: 30846037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinoma.
    Mosconi S; Beretta GD; Labianca R; Zampino MG; Gatta G; Heinemann V
    Crit Rev Oncol Hematol; 2009 Mar; 69(3):259-70. PubMed ID: 18977670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma and cholangiocarcinoma: an update.
    Yazici C; Niemeyer DJ; Iannitti DA; Russo MW
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):63-82. PubMed ID: 24245910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review on the Update of Combined Hepatocellular Cholangiocarcinoma.
    Komuta M; Yeh MM
    Semin Liver Dis; 2020 May; 40(2):124-130. PubMed ID: 31887773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinoma.
    Razumilava N; Gores GJ
    Lancet; 2014 Jun; 383(9935):2168-79. PubMed ID: 24581682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined hepatocellular-cholangiocarcinoma].
    Jeen YM; Jin SY
    Korean J Hepatol; 2007 Dec; 13(4):571-5. PubMed ID: 18159156
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenges in Diagnosing and Reporting Cholangiocarcinoma.
    El Jabbour T; Molnar A; Lagana SM
    Surg Pathol Clin; 2023 Sep; 16(3):599-608. PubMed ID: 37536891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatobiliary tumours.
    Simcock R
    Practitioner; 2001 Aug; 245(1625):668-74. PubMed ID: 11524939
    [No Abstract]   [Full Text] [Related]  

  • 20. Biliary tract cancer.
    Curley SA
    Cancer Treat Res; 1997; 90():273-307. PubMed ID: 9367089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.